Cargando…
Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations
Pharmacoproteomics is the study of disease-modifying and toxicity parameters associated with therapeutic drug administration, using analysis of quantitative and temporal changes to specific, predetermined, and select proteins, or to the proteome as a whole. Pharmacoproteomics is a rapidly evolving f...
Autores principales: | Nandal, Savita, Burt, Tal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343982/ https://www.ncbi.nlm.nih.gov/pubmed/28218733 http://dx.doi.org/10.3390/ijms18020448 |
Ejemplares similares
-
Pharmacometabolomics in Early‐Phase Clinical Development
por: Burt, T, et al.
Publicado: (2016) -
Precision medicine: from pharmacogenomics to pharmacoproteomics
por: Chambliss, Allison B., et al.
Publicado: (2016) -
Pharmacoproteomic characterisation of human colon and rectal cancer
por: Frejno, Martin, et al.
Publicado: (2017) -
Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes
por: Calamia, Valentina, et al.
Publicado: (2010) -
A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine
por: Calamia, Valentina, et al.
Publicado: (2014)